[Therapeutic possibilities using the induction of drug reducing enzymes].
D000818:Animals; D001728:Dicumarol / Q000378:metabolism / Q000627:therapeutic use; D003576:Electron Transport Complex IV / Q000627:therapeutic use; D004790:Enzyme Induction; D057487:Enzyme Therapy; D005110:Extracellular Space; D006651:Histocytochemistry; D006801:Humans; D006932:Hyperbilirubinemia / Q000188:drug therapy; D008099:Liver / Q000201:enzymology; D008659:Metabolic Diseases / Q000188:drug therapy*; D008854:Microscopy, Electron; D008862:Microsomes, Liver / Q000201:enzymology / Q000378:metabolism; D008930:Mitochondria, Liver / Q000201:enzymology; D004364:Pharmaceutical Preparations / Q000378:metabolism; D010634:Phenobarbital / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D010949:Plasma / Q000187:drug effects
D004364:Pharmaceutical Preparations; D001728:Dicumarol; D003576:Electron Transport Complex IV; D010634:Phenobarbital
Therapeutische Möglichkeiten durch die Induzierbarkeit arzneimittelabbauender Enzyme.